During the past two decades, researchers have been focusing on therapies aimed at the striking of cancer cells at the molecular level. The goal of specific molecular targeted therapies for cancer is for the agent to act like a “magic bullet” that selectively targets only the cancer cells. As the understanding of cancer cell biology evolves, it is hoped that more therapies will be developed to target only certain components of the cancer cell and that therapies will be designed to have minimal or no effects on normal cells, which is distinct from present day chemotherapy and radiotherapy. One of the targets of the molecular-based therapies is the HER (ErbB) family of transmembrane receptor tyrosine kinases. The tyrosine kinase receptors are located on the cell surface and bind with a variety of drugs, hormones and neurotransmitters.
The goal of this targeted therapy for cancer continuing education program is to provide pharmacists and imaging technologists with adequate information about developments in targeted therapies for treatment of various cancers. After studying the material presented here, you will be able to:
- Explain how targeted therapies have evolved and what protein molecules they interact with to arrest cancer growth
- Discuss the approved target agents and their role in treatment of cancer
- List the adverse effects of target agents used to treat cancers
This course is intended for an interprofessional audience, including pharmacists and imaging technologists.
Imaging technologists: Take this version of the course to ensure you receive appropriate credit.
This activity is approved for Category A continuing education credit by the American Society of Radiologic Technologists (ASRT) for 9/4/2015 to 10/1/2018.
This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat a self-learning activity for credit if it was reported in the same or any subsequent biennium.
Course Originally Released on:
Date of Most Recent Review:
Course Termination/Update Date:
Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. OnCourse Learning guarantees this educational activity is free from bias.
Please see CE Course Instructions to learn how to earn CE credit for this module.